Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04465487 |
Title | Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Regeneron Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Angeles Clinic and Research Institute - Clinic/Outpatient Facility | Los Angeles | California | 90025 | United States | Details | |
H.Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
START South Texas Accelerated Research Therapeutics | Grand Rapids | Michigan | 49503 | United States | Details | |
Hospital Universitario Vall d'Hebrón | Barcelona | 08035 | Spain | Details | ||
ICO l'Hospitalet - Hospital Duran i Reynals | Barcelona | 08908 | Spain | Details | ||
MD Anderson Cancer Center | Madrid | 28033 | Spain | Details | ||
Hospital Universitario Ramon y Cajal | Madrid | 28034 | Spain | Details | ||
Hospital Universitario Fundacion Jimenez | Madrid | 28040 | Spain | Details | ||
Hospital Universitario HM Sanchinarro | Madrid | 28050 | Spain | Details |